| Year |
Citation |
Score |
| 2019 |
Henise J, Fontaine SD, Hearn BR, Pfaff SJ, Schneider EL, Malato J, Wang D, Hann B, Ashley GW, Santi DV. In Vitro-In Vivo Correlation for the Degradation of Tetra-PEG Hydrogel Microspheres with Tunable β-Eliminative Crosslink Cleavage Rates International Journal of Polymer Science. 2019: 1-7. DOI: 10.1155/2019/9483127 |
0.307 |
|
| 2018 |
Hearn BR, Fontaine SD, Pfaff SJ, Schneider EL, Henise J, Ashley GW, Santi DV. Primary deuterium kinetic isotope effects prolong drug release and polymer biodegradation in a drug delivery system. Journal of Controlled Release : Official Journal of the Controlled Release Society. PMID 29577950 DOI: 10.1016/J.Jconrel.2018.03.021 |
0.309 |
|
| 2017 |
Kara E, Manna D, Løset GÅ, Schneider EL, Craik CS, Kanse S. Analysis of the substrate specificity of Factor VII activating protease (FSAP) and design of specific and sensitive peptide substrates. Thrombosis and Haemostasis. 117. PMID 28726978 DOI: 10.1160/Th17-02-0081 |
0.324 |
|
| 2016 |
Schneider EL, Hearn BR, Pfaff SJ, Fontaine SD, Reid R, Ashley GW, Grabulovski S, Strassberger V, Vogt L, Jung T, Santi DV. An approach for half-life extension of small antibody fragments that does not affect tissue uptake. Bioconjugate Chemistry. PMID 27657443 DOI: 10.1021/Acs.Bioconjchem.6B00469 |
0.321 |
|
| 2016 |
Schneider EL, Henise J, Reid R, Ashley GW, Santi DV. Subcutaneously administered self-cleaving hydrogel-octreotide conjugates provide very long-acting octreotide. Bioconjugate Chemistry. PMID 27253622 DOI: 10.1021/Acs.Bioconjchem.6B00188 |
0.315 |
|
| 2016 |
Schneider EL, Henise J, Reid R, Ashley GW, Santi DV. Hydrogel drug delivery system using self-cleaving covalent linkers for once-a-week administration of exenatide. Bioconjugate Chemistry. PMID 26930186 DOI: 10.1021/Acs.Bioconjchem.5B00690 |
0.319 |
|
| 2015 |
Schneider EL, Ashley GW, Dillen L, Stoops B, Austin NE, Malcolm BA, Santi DV. Half-life extension of the HIV-fusion inhibitor peptide TRI-1144 using a novel linker technology. European Journal of Pharmaceutics and Biopharmaceutics : Official Journal of Arbeitsgemeinschaft FüR Pharmazeutische Verfahrenstechnik E.V. 93: 254-9. PMID 25900863 DOI: 10.1016/J.Ejpb.2015.04.003 |
0.315 |
|
| 2014 |
Santi DV, Schneider EL, Ashley GW. Macromolecular prodrug that provides the irinotecan (CPT-11) active-metabolite SN-38 with ultralong half-life, low C(max), and low glucuronide formation. Journal of Medicinal Chemistry. 57: 2303-14. PMID 24494988 DOI: 10.1021/Jm401644V |
0.32 |
|
| 2013 |
Schneider EL, Robinson L, Reid R, Ashley GW, Santi DV. β-Eliminative releasable linkers adapted for bioconjugation of macromolecules to phenols. Bioconjugate Chemistry. 24: 1990-7. PMID 24171387 DOI: 10.1021/Bc4002882 |
0.3 |
|
| 2012 |
Santi DV, Schneider EL, Reid R, Robinson L, Ashley GW. Predictable and tunable half-life extension of therapeutic agents by controlled chemical release from macromolecular conjugates. Proceedings of the National Academy of Sciences of the United States of America. 109: 6211-6. PMID 22474378 DOI: 10.1073/Pnas.1117147109 |
0.336 |
|
| 2012 |
Schneider EL, Lee MS, Baharuddin A, Goetz DH, Farady CJ, Ward M, Wang CI, Craik CS. A reverse binding motif that contributes to specific protease inhibition by antibodies. Journal of Molecular Biology. 415: 699-715. PMID 22154938 DOI: 10.1016/J.Jmb.2011.11.036 |
0.305 |
|
| 2011 |
Franta Z, Sojka D, Frantova H, Dvorak J, Horn M, Srba J, Talacko P, Mares M, Schneider E, Craik CS, McKerrow JH, Caffrey CR, Kopacek P. IrCL1 - the haemoglobinolytic cathepsin L of the hard tick, Ixodes ricinus. International Journal For Parasitology. 41: 1253-62. PMID 21819989 DOI: 10.1016/J.Ijpara.2011.06.006 |
0.316 |
|
| 2010 |
He C, Nora GP, Schneider EL, Kerr ID, Hansell E, Hirata K, Gonzalez D, Sajid M, Boyd SE, Hruz P, Cobo ER, Le C, Liu WT, Eckmann L, Dorrestein PC, et al. A novel Entamoeba histolytica cysteine proteinase, EhCP4, is key for invasive amebiasis and a therapeutic target. The Journal of Biological Chemistry. 285: 18516-27. PMID 20378535 DOI: 10.1074/Jbc.M109.086181 |
0.329 |
|
| 2009 |
Dvorák J, Mashiyama ST, Sajid M, Braschi S, Delcroix M, Schneider EL, McKerrow WH, Bahgat M, Hansell E, Babbitt PC, Craik CS, McKerrow JH, Caffrey CR. SmCL3, a gastrodermal cysteine protease of the human blood fluke Schistosoma mansoni. Plos Neglected Tropical Diseases. 3: e449. PMID 19488406 DOI: 10.1371/Journal.Pntd.0000449 |
0.333 |
|
| 2008 |
Farady CJ, Egea PF, Schneider EL, Darragh MR, Craik CS. Structure of an Fab-protease complex reveals a highly specific non-canonical mechanism of inhibition. Journal of Molecular Biology. 380: 351-60. PMID 18514224 DOI: 10.1016/J.Jmb.2008.05.009 |
0.326 |
|
| 2007 |
Sojka D, Hajdusek O, Dvorák J, Sajid M, Franta Z, Schneider EL, Craik CS, Vancová M, Buresová V, Bogyo M, Sexton KB, McKerrow JH, Caffrey CR, Kopácek P. IrAE: an asparaginyl endopeptidase (legumain) in the gut of the hard tick Ixodes ricinus. International Journal For Parasitology. 37: 713-24. PMID 17336985 DOI: 10.1016/J.Ijpara.2006.12.020 |
0.328 |
|
| 2005 |
Schneider EL, King DS, Marletta MA. Amino acid substitution and modification resulting from Escherichia coli expression of recombinant Plasmodium falciparum histidine-rich protein II. Biochemistry. 44: 987-95. PMID 15654755 DOI: 10.1021/Bi048571H |
0.479 |
|
| 2005 |
Schneider EL, Marletta MA. Heme binding to the histidine-rich protein II from Plasmodium falciparum. Biochemistry. 44: 979-86. PMID 15654754 DOI: 10.1021/Bi048570P |
0.468 |
|
| 2002 |
Choi CY, Schneider EL, Kim JM, Gluzman IY, Goldberg DE, Ellman JA, Marletta MA. Interference with heme binding to histidine-rich protein-2 as an antimalarial strategy. Chemistry & Biology. 9: 881-9. PMID 12204687 DOI: 10.1016/S1074-5521(02)00183-7 |
0.562 |
|
| Show low-probability matches. |